About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Second Line Breast Cancer Trial

Second Line Breast Cancer Trial

NCT00635713·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

18–any

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

postmenopausal women with confirmation of breast cancer
objective evidence of recurrence or progression of breast cancer no more than 1 prior hormonal therapy for breast cancer

You may not be if

presence of life-threatening metastatic visceral disease
previous treatment with FASLODEX, ARIMIDEX or any aromatase inhibitor for breast cancer
more than 1 prior endocrine medical treatment for advanced breast cancer .

The record

StatusCompleted

PhasePhase 3

Taking part588

StartedMay 1997

UpdatedApr 10, 2009

Conditions

Advanced Breast Cancer